InvestorsHub Logo

W_W

Followers 7
Posts 260
Boards Moderated 0
Alias Born 07/22/2020

W_W

Re: None

Wednesday, 06/30/2021 2:09:38 PM

Wednesday, June 30, 2021 2:09:38 PM

Post# of 43852
There are two groups of patient:
High risk group, which need to take chemo. They did with or without Multikine within this group, the results are no improvement, consider 0% improvement.
Low risk group, which don't need to take chemo, they also did with or without Multikine within this group, the results are 14% improvement @ 5 years. They will apply for FDA approval for this group.
They didn't give out the group sizes, but P value has some indication.
Within high risk group, they didn't do Multikine + no chemo vs no Multikine +chemo. This comparison will show whether Multikine is possible to replace chemo or not. They may do it later after Multikine is approved by FDA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News